erythroid enhancer bcl11a subject genetic variation determines fetal hemoglobin level
genome-wide association studies gwass ascertained numerous trait-associated common genetic variants frequently localized regulatory dna found common genetic variation bcl11a associated fetal hemoglobin hbf level lies noncoding sequences decorated erythroid enhancer chromatin signature fine-mapping uncovers motif-disrupting common variant associated reduced transcription factor tf binding modestly diminished bcl11a expression elevated hbf surrounding sequences function vivo developmental stage-specific lineage-restricted enhancer genome engineering reveals enhancer required erythroid b-lymphoid cells bcl11a expression findings illustrate gwass may expose functional variants modest impact within causal elements essential appropriate gene expression propose gwas-marked bcl11a enhancer represents attractive target therapeutic genome engineering beta-hemoglobinopathies
